MIRA INFORM REPORT

Report Date :

02.01.2012

IDENTIFICATION DETAILS

Name :	ARCH PHARMALABS LIMITED (w.e.f. 31.03.2004)
Formerly Known As :	ARCH COMMERZ PRIVATE LIMITED
Registered Office :	H Wing, 4^th Floor, Tex Centre, Narayan Properties, Chandivali, Off Saki Vihar Road, Andheri (East), Mumbai – 400 072, Maharashtra
Country :	India
Financial (as on) :	31.03.2010
Date of Incorporation :	02.04.1993
Com. Reg. No.:	11-150891
Capital Investment / Paid-up Capital :	Rs.212.300 Millions
CIN No.: [Company Identification No.]	U24231MH1993PLC150891
TAN No.: [Tax Deduction & Collection Account No.]	MUMA19603D
PAN No.: [Permanent Account No.]	AACCM0306Q
Legal Form :	A Closely Held Public Limited Liability Company
Line of Business :	Manufacturing of Pharmaceutical Intermediates.
No. of Employees :	1500 (Approximately)

RATING & COMMENTS

MIRA’s Rating :

A (59)

RATING		STATUS	PROPOSED CREDIT LINE
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large

Maximum Credit Limit :	USD 18700000
Status :	Good
Payment Behaviour :	Regular
Litigation :	Clear
Comments :	Subject is a well established company having fine track. Financial position of the company appears to be sound. Trade relations are reported as fair. Business is active. Payments are reported to be correct and as per commitments. The company can be considered normal for business dealings at usual trade terms and conditions.

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – September 30, 2011

Country Name	Previous Rating (30.06.2011)	Current Rating (30.09.2011)
India	A1	A1

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

INFORMATION PARTED BY

Name :	Mr. Vikas Kedia
Designation :	Company Secretary and DGM Finance
Contact No.:	91-22-28470555

LOCATIONS

Registered Office / Corporate Office :	H Wing, 4^th Floor, Tex Centre, Narayan Properties, Chandivali, Off Saki Vihar Road, Andheri (East), Mumbai - 400 072, Maharashtra, India
Tel. No.:	91-22-28470555 / 33089200 / 33089400 / 40756789
Fax No.:	91-22-28471234 / 1002
E. Mail.:	info@archpharmalabs.com sudhir.nagar@archpharmalabs.com
Website:	www.archpharmalabs.com
Area :	5000 Sq. ft.
Location :	Owned
Head Office :	Titanic Building, 3^rd Floor, Tex Center Off 5, Mumbai, Maharashtra, India
Tel. No.:	91-22-28470555
Fax No.:	91-22-28471012
Plant:	1. Survey No. 323, Gundlamachnur Village, Hathnoora Mandal, District Medak – 502 296, Andhra Pradesh, India Tel. No.: 91-22-28560555/0560 Fax No.: 91-22-28561234/1002 E-Mail : archcom@mtnl.net.in archfin@vsnl.com infor@archpharmalabs.com Area : 5500 Sq.fts Location : Owned 2. Survey No. 280, Mittapally Village, Siddipet – 502 375, Medak, Andhra Pradesh, India 3. Plot No. T- 84, 85 and 86 MIDC Tarapur, Taluka Palghar, District Thane, Maharashtra, India 4. Plot No. G-4 and G-5, Kharvai MIDC, Badlapur, District Thane - 421 503, Maharashtra, India 5. Vitalifa Laboratories, Village Pathreri, Bilaspur Tauru Road, District Gurgoan – 122 001, Haryana, India 6. Plot No. G-6, MIDC Taloja, Taloja Industrial Area, Village Navade, Taluka Panvel, District Raigad, Maharashtra, India 7. Corporate R and D Centre - I, Plot No. 21, MIDC, Chemical Zone , Taloja Industrial Area, Village Navade, Taluka Panvel, District Raigad – 410 208, Maharashtra, India 8. Corporate R and D Centre - II, Plot No. C-424, TTC Turbhe, MIDC Industrial Area, Navi Mumbai, Maharashtra, India 9. Plot No. W-45 (C) Anand Nagar, Additional Ambernath District Thane - 421 506, Maharashtra, India 10. V-8, MIDC, Taloja, Raigad, Maharashtra, India
Branch:	Located at:- 1. Sainath, 8-2-120/86/10/2, Muncipal No. 389, Road No. 14, Banjara hills, Hyderabad - 500 034, Andhra Pradesh 2. Shop No.3, Village Pabhat, Chandigarh Road, Zirakpur District, Ropar, Punjab

DIRECTORS

As on 29.09.2010

Name :	Mr. Ajit Annu Kamath
Designation :	Chairman and Managing Director
Address :	404, I la Apartments, Sector 4, R. O. P. 7, Chrkop, Kandivli (West), Mumbai-400067, Maharashtra, India
Date of Birth/Age :	12.12.1969
Qualification :	Graduate
Date of Appointment :	01.11.2003
DIN No. :	00032799

Other Directorship:

S.No.	CIN	Name of the Company	Current designation of the director	Date of appointment at current designation	Original date of appointment	Date of cessation	Company Status	Defaulting status
1	U67190MH1994PTC078769	ANHITA FINANCIAL SERVICES (BOMBAY) PRIVATE LIMITED	Director	6/6/1994	6/6/1994	26/03/2006	Active	NO
2	U65993MH1997PTC107197	ARCH INVESTMENT PRIVATE LIMITED	Director	10/4/1997	10/4/1997	-	Active	NO
3	U24233MH2000PTC126987	ARCH HERBALS PRIVATE LIMITED	Director	5/6/2000	5/6/2000	-	Active	NO
4	U51900MH2000PTC127806	ARCH IMPEX PRIVATE LIMITED	Director	19/07/2000	19/07/2000	-	Active	NO
5	U15499MH2000PTC129255	ARCH PHYTOCHEMICALS PRIVATE LIMITED	Director	19/10/2000	19/10/2000	-	Active	NO
6	U24231MH2000PLC129882	ARCH PHARMACHEM LIMITED	Director	29/07/2003	29/07/2003	-	Active	NO
7	U24231MH1993PLC150891	ARCH PHARMALABS LIMITED	Managing director	1/11/2008	1/11/2003	-	Active	NO
8	U21000MH1996PTC103102	AVANT CAPITAL SERVICES PRIVATE LIMITED	Director	15/06/2005	15/06/2005	-	Active	NO
9	U45200AP2006PTC051039	MARM REALTY PRIVATE LIMITED	Director	1/9/2006	1/9/2006	-	Active	NO
10	U55204MH2007PTC166795	ACCENTURE HOSPITALITY PRIVATE LIMITED	Director	6/1/2007	6/1/2007	-	Strike off	NO
11	U24239AP2003PLC042232	ARCH LIFE SCIENCES LIMITED	Director	2/4/2007	2/4/2007	-	Active	NO
12	U65190MH2007PTC171972	A M R INVESTMENTS PRIVATE LIMITED	Director	25/06/2007	25/06/2007	-	Active	NO
13	U24100MH2000PLC125507	NIPRO TUBE GLASS LIMITED	Director	31/07/2007	31/07/2007	-	Active	NO
14	U24110AP1993PLC015533	ARCH FINECHEMICALS LIMITED	Director	29/09/2007	22/08/2007	-	Active	NO
15	U45200MH2007PLC175780	ARCH INFRA VENTURES LIMITED	Director	7/11/2007	7/11/2007	-	Active	NO
16	U24230MH2004PTC147388	BENZOCHEM LIFESCIENCES PRIVATE LIMITED	Director	10/7/2008	10/7/2008	12/3/2010	Active	NO
17	U24233MH2008PTC186600	ARISTO HERBOFARM PRIVATE LIMITED	Director	9/9/2008	9/9/2008	5/3/2009	Active	NO
18	U24233MH2008PTC186599	AIM HERBOFARM PRIVATE LIMITED	Director	9/9/2008	9/9/2008	5/3/2009	Active	NO
19	L24110AP1993PLC016112	AVON ORGANICS LIMITED	Managing director	1/8/2009	31/01/2009	-	Active	NO
20	U24239MH2011PLC213956	AMRA REMEDIES LIMITED	Director	23/02/2011	23/02/2011	-	Active	NO
21	U01403MH2011PTC218636	ARCH AGROCHEMICALS PRIVATE LIMITED	Director	14/06/2011	14/06/2011	-	Active	NO
22	U24100MH2011PLC223168	AMRA RENAL CARE LIMITED	Director	17/10/2011	17/10/2011	-	Active	NO

Name :	Mr. Manoj Tejraj Jain
Designation :	Deputy Managing Director
Address :	Flat No. 4-A, Shefali, Mahim Makarand Society, 114, SVS Marg, Mahim, Mumbai – 400016, Maharashtra, India
Date of Birth/Age :	20.03.1970
Date of Appointment :	01.11.2003
DIN No. :	00034727

Other Directorship:

S.No.	CIN	Name of the Company	Current designation of the director	Date of appointment at current designation	Original date of appointment	Date of cessation	Company Status	Defaulting status
1	U67190MH1994PTC078769	ANHITA FINANCIAL SERVICES (BOMBAY) PRIVATE LIMITED	Director	6/6/1994	6/6/1994	26/03/2006	Active	NO
2	U65993MH1997PTC107197	ARCH INVESTMENT PRIVATE LIMITED	Director	10/4/1997	10/4/1997	-	Active	NO
3	U24233MH2000PTC126987	ARCH HERBALS PRIVATE LIMITED	Director	5/6/2000	5/6/2000	-	Active	NO
4	U51900MH2000PTC127806	ARCH IMPEX PRIVATE LIMITED	Director	19/07/2000	19/07/2000	-	Active	NO
5	U15499MH2000PTC129255	ARCH PHYTOCHEMICALS PRIVATE LIMITED	Director	19/10/2000	19/10/2000	-	Active	NO
6	U24231MH2000PLC129882	ARCH PHARMACHEM LIMITED	Director	29/07/2003	29/07/2003	-	Active	NO
7	U24231MH1993PLC150891	ARCH PHARMALABS LIMITED	Whole-time director	1/11/2008	1/11/2003	-	Active	NO
8	U21000MH1996PTC103102	AVANT CAPITAL SERVICES PRIVATE LIMITED	Director	15/06/2005	15/06/2005	-	Active	NO
9	U55204MH2007PTC166795	ACCENTURE HOSPITALITY PRIVATE LIMITED	Director	6/1/2007	6/1/2007	-	Strike off	NO
10	U24239AP2003PLC042232	ARCH LIFE SCIENCES LIMITED	Director	2/4/2007	2/4/2007	-	Active	NO
11	U65190MH2007PTC171972	A M R INVESTMENTS PRIVATE LIMITED	Director	25/06/2007	25/06/2007	-	Active	NO
12	U24100MH2000PLC125507	NIPRO TUBE GLASS LIMITED	Managing director	28/06/2010	31/07/2007	1/10/2011	Active	NO
13	U24110AP1993PLC015533	ARCH FINECHEMICALS LIMITED	Director	29/09/2007	22/08/2007	-	Active	NO
14	U45200MH2007PLC175780	ARCH INFRA VENTURES LIMITED	Director	7/11/2007	7/11/2007	-	Active	NO
15	U24230MH2004PTC147388	BENZOCHEM LIFESCIENCES PRIVATE LIMITED	Director	10/7/2008	10/7/2008	12/3/2010	Active	NO
16	U24233MH2008PTC186600	ARISTO HERBOFARM PRIVATE LIMITED	Director	9/9/2008	9/9/2008	5/3/2009	Active	NO
17	U24233MH2008PTC186599	AIM HERBOFARM PRIVATE LIMITED	Director	9/9/2008	9/9/2008	5/3/2009	Active	NO
18	L24110AP1993PLC016112	AVON ORGANICS LIMITED	Director	29/09/2009	31/01/2009	-	Active	NO
19	U24239MH2011PLC213956	AMRA REMEDIES LIMITED	Director	23/02/2011	23/02/2011	-	Active	NO
20	U01403MH2011PTC218636	ARCH AGROCHEMICALS PRIVATE LIMITED	Director	14/06/2011	14/06/2011	-	Active	NO
21	U24100MH2011PLC223168	AMRA RENAL CARE LIMITED	Director	17/10/2011	17/10/2011	-	Active	NO

Name :	Mr. Mallikarjuna Reddy Tirumalareddy
Designation :	Vice Chairman
Address :	B-13, Madhura Nagar, S.R. Nagar P.O., Hyderabad-500038, Andhra Pradesh, India
Date of Birth/Age :	15.04.1960
Date of Appointment :	04.04.1993
DIN No. :	00298545

Other Directorship:

S.No.	CIN	Name of the Company	Current designation of the director	Date of appointment at current designation	Original date of appointment	Company Status	Defaulting status
1	U24231MH1993PLC150891	ARCH PHARMALABS LIMITED	Whole-time director	1/10/2008	4/4/1993	Active	NO
2	U65993AP1995PTC019440	SAINATH INVESTMENTS PRIVATE LIMITED	Director	14/02/1995	14/02/1995	Active	NO
3	U99999AP1995PLC019510	PLANETWILDLIFE.COM (INDIA) LIMITED	Director	1/4/2010	21/02/1995	Active	NO
4	U85110KA1995PLC021495	ROSETTE AGRO-TECH LIMITED	Director	12/10/1995	12/10/1995	Active	NO
5	L01122AP1995PLC019311	ROSETTE AGRO-TECH LIMITED	Director	12/10/1995	12/10/1995	Dormant	NO
6	U51397AP1995PTC022674	SAINATH MEDICAL SYSTEMS PRIVATE LIMITED	Director	30/11/1998	30/11/1998	Active	NO
7	U45200AP2006PTC051039	MARM REALTY PRIVATE LIMITED	Director	1/9/2006	1/9/2006	Active	NO
8	U74900AP2008PTC059412	SAINATH HOSPITALITY PRIVATE LIMITED	Director	29/05/2008	29/05/2008	Active	NO

Name :	Mr. Rajendra Kumar Padmanabhan Kaimal
Designation :	Executive Director
Address :	Flat No. 1202, Sector R-3, C Wing, Orchid Enclave, Nahar’s Amrit Shakti, Chandivali, Andheri (East), Mumbai – 400072, Maharashtra, India
Date of Birth/Age :	23.06.1973
Date of Appointment :	01.11.2003
DIN No. :	00032839

Other Directorship:

No.	CIN	Name of the Company	Current designation of the director	Date of appointment at current designation	Original date of appointment	Date of cessation	Company Status	Defaulting status
1	U24231MH2000PLC129882	ARCH PHARMACHEM LTD	Director	29/07/2003	29/07/2003	-	Active	NO
2	U51900MH2000PTC127806	ARCH IMPEX PRIVATE LIMITED	Director	17/09/2003	17/09/2003	-	Active	NO
3	U24231MH1993PLC150891	ARCH PHARMALABS LIMITED	Whole-time director	1/11/2008	1/11/2003	-	Active	NO
4	U24239AP2003PLC042232	ARCH LIFE SCIENCES LIMITED	Director	2/4/2007	2/4/2007	-	Active	NO
5	U65190MH2007PTC171972	A M R INVESTMENTS PRIVATE LIMITED	Director	25/06/2007	25/06/2007	-	Active	NO
6	U24100MH2000PLC125507	NIPRO TUBE GLASS LIMITED	Director	31/07/2007	31/07/2007	24/05/2011	Active	NO
7	U24110AP1993PLC015533	ARCH FINECHEMICALS LIMITED	Director	29/09/2007	22/08/2007	-	Active	NO
8	U45200MH2007PLC175780	ARCH INFRA VENTURES LIMITED	Director	7/11/2007	7/11/2007	-	Active	NO
9	U24230MH2004PTC147388	BENZOCHEM LIFESCIENCES PRIVATE LIMITED	Director	10/7/2008	10/7/2008	12/3/2010	Active	NO
10	L24110AP1993PLC016112	AVON ORGANICS LIMITED	Additional director	31/01/2009	31/01/2009	1/8/2009	Active	NO
11	U24239MH2011PLC213956	AMRA REMEDIES LIMITED	Director	23/02/2011	23/02/2011	-	Active	NO
12	U01403MH2011PTC218636	ARCH AGROCHEMICALS PRIVATE LIMITED	Director	14/06/2011	14/06/2011	-	Active	NO
13	U24100MH2011PLC223168	AMRA RENAL CARE LIMITED	Director	17/10/2011	17/10/2011	-	Active	NO

Name :	Ms. Rajadhyaksha Vandana Makarand
Designation :	Nominee Director
Address :	301, 3^rd Floor, LAxmi Gopal Hatiskar Marg, Prabhadevi, Mumbai – 400025, Maharashtra, India
Date of Birth/Age :	09.10.1971
Date of Appointment :	19.07.2007
DIN No. :	00164120

Other Directorship:

S.No.	CIN	Name of the Company	Current designation of the director	Date of appointment at current designation	Original date of appointment	Date of cessation	Company Status	Defaulting status
1	U92100MH2000PLC127832	CAFE NETWORK LIMITED	Director	29/06/2001	29/06/2001	27/06/2008	Active	YES
2	U57909DL2000PTC103931	WEBQUITY E-MARKETING PRIVATE LIMITED	Director	14/03/2002	14/03/2002	-	Strike off	NO
3	U24231MH1993PLC150891	ARCH PHARMALABS LIMITED	Nominee director	19/07/2007	19/07/2007	-	Active	NO
4	U34102DL1989PLC034982	SAINIK MINING AND ALLIED SERVICES LIMITED	Nominee director	5/6/2009	5/6/2009	-	Active	NO
5	U24230TN1980PLC008382	MALLADI DRUGS AND PHARMACEUTICALS LIMITED	Nominee director	30/09/2010	18/06/2010	-	Active	NO

Name :	Mr. Sunil Vasantrao Diwakar
Designation :	Nominee Director
Address :	C-002, Shreejiville, Opposite Nitin Company, Almeda Road, Panch Pakhadi, Thane (West), Mumbai – 400602, Maharashtra, India
Date of Birth/Age :	22.05.1963
Date of Appointment :	28.01.2008
DIN No. :		00089266

Other Directorship:

S.No.	CIN	Name of the Company	Current designation of the director	Date of appointment at current designation	Original date of appointment	Date of cessation	Company Status	Defaulting status
1	U92100MH2000PLC127832	CAFE NETWORK LIMITED	Director	29/06/2001	29/06/2001	27/06/2008	Active	YES
2	U57909DL2000PTC103931	WEBQUITY E-MARKETING PRIVATE LIMITED	Director	14/03/2002	14/03/2002	-	Strike off	NO
3	U24231MH1993PLC150891	ARCH PHARMALABS LIMITED	Nominee director	19/07/2007	19/07/2007	-	Active	NO
4	U34102DL1989PLC034982	SAINIK MINING AND ALLIED SERVICES LIMITED	Nominee director	5/6/2009	5/6/2009	-	Active	NO
5	U24230TN1980PLC008382	MALLADI DRUGS AND PHARMACEUTICALS LIMITED	Nominee director	30/09/2010	18/06/2010	-	Active	NO

Name :	Mr. Koppisetty Srinivas
Designation :	Nominee Director
Address :	Flat No. 304, Building No. 15, Mhada Residential Complex, Oshiwara, Andheri (West), Mumbai – 400053, Maharashtra, India
Date of Birth/Age :	17.05.1963
Date of Appointment :	19.12.2007
DIN No. :	00514607

Other Directorship:

S.No.	CIN	Name of the Company	Current designation of the director	Date of appointment at current designation	Original date of appointment	Date of cessation	Company Status	Defaulting status
1	U65999MH2002PTC134398	BTS INVESTMENT ADVISORS PRIVATE LIMITED	Director	4/7/2006	4/7/2006	-	Active	NO
2	U32200MH1999PLC121164	MICROQUAL TECHNO LIMITED	Nominee director	28/06/2007	28/06/2007	28/10/2010	Active	NO
3	U74900MH2007PTC169253	BELVOIR ADVISORS PRIVATE LIMITED	Director	29/06/2007	29/06/2007	5/10/2009	Active	NO
4	U74994MH1996PTC101050	RELIABLE AUTOTECH PRIVATE LIMITED	Director	16/07/2007	16/07/2007	18/05/2009	Active	NO
5	U24231MH1993PLC150891	ARCH PHARMALABS LIMITED	Nominee director	19/12/2007	19/12/2007	9/12/2010	Active	NO
6	U74899DL1993PLC056293	QAI (INDIA) LIMITED	Additional director	1/2/2008	1/2/2008	-	Active	NO
7	U34100MH1989PTC051360	RELIABLE TECHNOCRATS PRIVATE LIMITED	Director	11/2/2008	11/2/2008	18/05/2009	Active	NO
8	U28920PN1995PTC091232	MANTRI METALLICS PRIVATE LIMITED	Director	26/09/2008	7/3/2008	--	Active	NO
9	L24231CH1996PLC017755	PARABOLIC DRUGS LIMITED	Director	27/09/2008	30/04/2008	-	Active	NO
10	U45200AP2005PLC048258	SAI SUDHIR INFRASTRUCTURES LIMITED	Director	14/08/2008	5/8/2008	-	Active	NO
11	U05005AP1995PLC021217	OCEAN SPARKLE LIMITED	Nominee director	28/09/2009	21/03/2009	7/7/2010	Active	NO
12	U63090TN1994PTC027880	CARAVEL LOGISTICS PRIVATE LIMITED	Nominee director	27/07/2009	27/07/2009	-	Active	YES
13	U71110DL2000PTC189230	CARZONRENT (INDIA) PRIVATE LIMITED	Nominee director	10/6/2011	19/01/2011	-	Active	NO
14	U40108AP2010PLC067900	SAISUDHIR ENERGY LIMITED	Additional director	19/04/2011	19/04/2011	-	Active	NO

KEY EXECUTIVES

Name :	Mr. Vikas B. Kedia
Designation :	Company Secretary and DGM Finance
Address :	Flat No. 201, C-Wing, Krishna Building, Vasant Sagar Complex, Thakur Village, Kandivali (East), Mumbai – 400101, Maharashtra, India
Date of Birth/Age :	08.07.1976
Date of Appointment :	26.12.2003
PAN No. :	AMZPK9885E

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

(As On 29.09.2010)

Names of Shareholders	No. of Shares
Ajit Annu Kamath	581967
Manoj Tejraj Jain	194061
Mallikarjuna Reddy Tirumalareddy	510
Rajendra Kumar Padmanabhan Kaimal	230000

(As On 29.09.2010)

Equity Share Breakup	Percentage
Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others	2.74
Nationalized or Other Banks	0.02
Venture Capital	48.51
Bodies corporate	30.16
Directors or relatives of Directors	11.44
Other top fifty shareholders	4.75
Others	2.38
Total	100.00

BUSINESS DETAILS

Line of Business :

Manufacturing of Pharmaceutical Intermediates.

Products :

Item Code No.	Product Description
29159000	CMIC - Chloride
29159000	DICMIC - Chloride
29159000	FCMIC - Chloride

GENERAL INFORMATION

Customers :

· Chemical Company

· Others

No. of Employees :

1500 (Approximately)

Bankers :

· Karnataka Bank Limited

Overseas Branch, 2 Firuz Ara, 160, M.K. Road, Cooperage, Mumbai - 400 021, Maharashtra, India

Tel. No. 91-22-22885016/17

Fax No. 91-22-22020463

· Axis Bank Limited

Universal Insurance Building, Sir P. M. Road, Fort Branch, Mumbai-400001, Maharashtra, India

Tel. No. 91-22-22835782/84/87/89

Fax No. 91-22-22844113

· Export Import Bank of India, Centre One Building, Floor 21, World Trade Centre, Cuffe Parade, Mumbai – 400005, Maharashtra, India

· DBS Bank Limited

· HDFC Bank Limited

· IL and FS Limited

· India Bank

· State Bank of India

· State Bank of Indore

· State Bank of Mysore

· State Bank of Patiala

· YES Bank Limited

· Canara Bank

· The Greater Bombay Co-operative Bank Limited

· The Karur Vysya Bank Limited

· Bank of India, Cuffe Parade, Mumbai – 400005, Maharashtra, India

Facilities :

Secured Loans	31.03.2010 Rs. in millions	31.03.2009 Rs. in millions
a) Debentures
Non – Convertible Debentures (Note – a)	200.000	300.000
b) Term Loan (Note – b)
From Bank	3682.800	2901.300
From Institution	805.700	645.800
c) Working Capital / Short Term Loans (Note – c)	4268.300	2810.600
d) Loans under Hire purchase arrangements (Note – d)	13.000	22.100
e) Interest accrued and due	31.600	50.400
Total	9001.400	6730.200

Notes

a) Non-Convertible Debentures referred to in (a) above are secured by subservient charge on the movable assets of the company and personal guarantee of the company's promoter directors. Debentures are redeemable at par in one or more installments on various dates with the earliest redemption being on 28.02.2011 and the last being in 28.02.2012.

b) The Term Loans referred to in (b) above are secured by first pari-passu charge on the fixed assets, second pari-passu charge on the current assets and personal guarantee of the company's promoter directors except term loan of Rs.676.100 Millions (Previous year Rs.435.600 Millions) which is secured by residual charge on the entire fixed assets and current assets of the company.

c) Working Capital Loans referred to in (c) above are secured by first pari-passu charge on the current assets, second pari-passu charge on the fixed assets and personal guarantee of the company's promoter directors.

d) Loans under Hire Purchase agreements referred to in (d) above are secured by the hypothecation of the specific vehicle financed by the respective bank.

Unsecured Loans	31.03.2010 Rs. in millions	31.03.2009 Rs. in millions
Debentures (Redeemable within three years)	100.000	750.000
Long Term From Others (Rs.1.000 Million payable within one year)	1.000	2.100
Short Term From Banks/Institutions	2101.500	1009.600
Deferred Sales tax Liability	57.000	57.000
Total	2259.500	1818.700

Banking Relations :

Satisfactory

Financial Institution :

· LIC of India

· DEG, Germany

Auditors :

Name 1 :

Nayak and Rane

Chartered Accountants

Address:

501, Siddhivinayak Annexe, C – Wing, S.J. Marg, Lower Parel, Mumbai – 400013, Maharashtra, India

Name 2 :

Chaturvedi and Shah

Chartered Accountants

Address :

714-715, Tulsiani Chambers, 212, Nariman Point, Mumbai – 400021, Maharashtra, India

Sister Concern:

· Arch Financial Services (Bom) Private Limited

Engaged in providing financial services

· Arch Phytochemicals Private Limited

Engaged in Preparing Registration Dossiers for Homeopathic medicines

· Avon Organics Limited

(CIN No. : L24110AP1993PLC16112)

Manufacturing Facility : Sadasivpeth, Near Hyderabad and Solapur, Maharashtra

· Benzochem Lifesciences Private Limited

Manufacturing Facility : Tarapur, Near Mumbai

· Arch Herbals Private Limited

· Arch Impex Private Limited

· Arch Investment Private Limited

· Arch Pharmachem Limited

· Avant Capital Services Private Limited

· AMR Investments Private Limited

· Accenture Hospitality Private Limited

· Marm Realty Private Limited

· Tube Glass Containers Limited

Subsidiaries :

· Arch Life Sciences Limited (Formerly Sibra Pharmaceuticals Limited)

(CIN No. : U24239AP2003PLC042232)

Manufacturing Facility : Medak, Near Hyderabad

· Arch Finechemicals Limited (Formerly Watsol Organics Limited)

(CIN No. : U24110AP1993PLC015533)

Manufacturing Facility : Medak, Near Hyderabad

· Arch Pharmalabs (USA) Inc.

CAPITAL STRUCTURE

(As on 31.03.2010)

Authorised Capital :

No. of Shares	Type	Value	Amount
30000000	Equity Shares	Rs.10/- each	Rs.300.000 millions
10000000	Preference Shares	Rs.10/- each	Rs.100.000 millions
	Total		Rs. 400.000 millions

Issued, Subscribed & Paid-up Capital :

No. of Shares	Type	Value	Amount
21234022	Equity Shares	Rs.10/- each	Rs.212.300 Millions

FINANCIAL DATA

[all figures are in Rupees Millions]

ABRIDGED BALANCE SHEET

SOURCES OF FUNDS		31.03.2010	31.03.2009	31.03.2008
SHAREHOLDERS FUNDS
1] Share Capital		212.300	212.300	212.340
2] Share Application Money		300.000	0.000	0.000
3] Reserves & Surplus		4158.200	3649.400	3281.681
4] (Accumulated Losses)		0.000	0.000	0.000
NETWORTH		4670.500	3861.700	3494.021
LOAN FUNDS
1] Secured Loans		9001.400	6730.200	2837.619
2] Unsecured Loans		2259.500	1818.700	1011.183
TOTAL BORROWING		11260.900	8548.900	3848.802
DEFERRED TAX LIABILITIES		425.100	291.800	205.614
TOTAL		16356.500	12702.400	7548.437
APPLICATION OF FUNDS
FIXED ASSETS [Net Block]		5770.800	4608.900	2710.252
Capital work-in-progress		674.200	1172.200	0.000
INVESTMENT		492.400	717.900	790.849
Foreign Currency Monetary Item Translation Difference Account		0.700	5.000	0.000
CURRENT ASSETS, LOANS & ADVANCES
	Inventories	3743.400	3109.400	1491.210
	Sundry Debtors	4771.500	3112.700	1695.545
	Cash & Bank Balances	501.300	408.300	960.317
	Other Current Assets	0.000	0.000	0.000
	Loans & Advances	2889.200	1682.200	684.937
Total Current Assets		11905.400	8312.600	4832.009
Less : CURRENT LIABILITIES & PROVISIONS
	Sundry Creditors	821.700	1089.600	703.323
	Other Current Liabilities	1646.900	1010.900	82.157
	Provisions	18.400	13.700	10.990
Total Current Liabilities		2487.000	2114.200	796.470
Net Current Assets		9418.400	6198.400	4035.539
MISCELLANEOUS EXPENSES		0.000	0.000	11.797
TOTAL		16356.500	12702.400	7548.437

PROFIT & LOSS ACCOUNT

	PARTICULARS		31.03.2010	31.03.2009	31.03.2008
	SALES
		Income	10233.700	7133.300	5141.993
		Other Income	64.500	20.700	34.654
		TOTAL (A)	10298.200	7154.000	5176.647
Less	EXPENSES
		Cost of Materials	6403.100	4682.600	3442.808
		Manufacturing and Other Expenses	1409.300	1089.200	749.932
		TOTAL (B)	7812.400	5771.800	4192.740
Less	PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C)		2485.800	1382.200	983.907
Less	FINANCIAL EXPENSES (D)		1312.400	596.400	357.057
	PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)		1173.400	785.800	626.850
Less/ Add	DEPRECIATION/ AMORTISATION (F)		458.700	240.100	160.619
	PROFIT BEFORE TAX (E-F) (G)		714.700	545.700	466.231
Less	TAX (H)		205.900	178.000	131.734
	PROFIT AFTER TAX (G-H) (I)		508.800	367.700	334.497
Add	PREVIOUS YEARS’ BALANCE BROUGHT FORWARD		1138.600	855.400	658.466
Less	APPROPRIATIONS
		Debenture Redemption Reserve Account	(36.100)	84.500	3.720
		Short / Excess Provision for Tax	0.000	0.000	4.693
		Proposed Dividend on Preference Shares	0.000	0.000	0.798
		Distribution Tax thereon	0.000	0.000	128.333
	BALANCE CARRIED TO THE B/S		1683.500	1138.600	855.419
	EARNINGS IN FOREIGN CURRENCY
		Export Earnings	3474.200	1666.600	700.413
		Others	484.400	78.000	29.584
	TOTAL EARNINGS		3958.600	1744.600	729.997
	IMPORTS
		Raw Materials	2228.200	1469.100	843.428
		Capital Goods	5.300	63.900	49.249
	TOTAL IMPORTS		2233.500	1533.000	892.677
	Earnings Per Share (Rs.)		23.96	17.31	15.32

Particulars	31.03.2011
Sales Turnover (Approximately)	12500.000

Expected Sales ( 2011-2012 ) : More Than Rs.15000.000 Millions

The above information has been parted by Mr. Vikas Kedia

KEY RATIOS

PARTICULARS		31.03.2010	31.03.2009	31.03.2008
PAT / Total Income	(%)	4.94	5.14	6.46
Net Profit Margin (PBT/Sales)	(%)	6.98	7.65	9.07
Return on Total Assets (PBT/Total Assets}	(%)	4.04	4.22	6.18
Return on Investment (ROI) (PBT/Networth)		0.15	0.14	0.13
Debt Equity Ratio (Total Liability/Networth)		2.94	2.76	1.33
Current Ratio (Current Asset/Current Liability)		4.79	3.93	6.07

LOCAL AGENCY FURTHER INFORMATION

Check List by Info Agents	Available in Reports (Yes/No)
Year of Establishment	YES
Locality Of The Firm	YES
Constitution of the firm	YES
Premises Details	YES
Type of Business	YES
Line of Business	YES
Promotor’s background	--
No. of Employees	YES
Name of person contacted	YES
Designed of contact person	YES
Turnover of firm for last three years	YES
Profitability for last three years	NO
Reasons for variation <> 20%	--
Estimation for coming financial year	YES
Capital of the business	YES
Details of Sister Concern	YES
Major Suppliers	NO
Major Customers	NO
Payments Terms	YES
Export / Import details (if applicable)	YES
Market information	--
Litigation that the firm / promoter involved in	--
Banking details	YES
Banking facility details	NO
Conduct of the banking account	--
Buyer visit details	--
Financial, if provided	NO
Incorporation details, if applicable	--
Last accounts filed at ROC	--
Major Shareholders, if available	--

FORM 8 :

Corporate identity number of the company	U24231MH1993PLC150891
Name of the company	ARCH PHARMALABS LIMITED
Address of the registered office or of the principal place of business in India of the company	H Wing, 4^th Floor, Tex Centre, Narayan Properties, Chandivali, Off Saki Vihar Road, Andheri (East), Mumbai – 400 072, Maharashtra, India
This form is for	Creation of charge
Type of charge	Movable property
Particular of charge holder	Export Import Bank of India, Centre One Building, Floor 21, World Trade Centre, Cuffe Parade, Mumbai – 400005, Maharashtra, India
Nature of instrument creating charge	Unattested Deed of Hypothecation (DOH) of moveable assets dated 7th April 2011 executed by Arch Pharmalabs Limited (the Borrower) in favour of Export-Import Bank of India (Exim Bank) for Rs.500.000 millions, a copy whereof is attached hereto.
Date of instrument Creating the charge	07.04.2011
Amount secured by the charge	Rs.500.000 Millions
Brief of the principal terms an conditions and extent and operation of the charge	Rate of interest : 11.50% per annum payable monthly subject to reset in accordance with the Loan Agreement. Terms of repayment : The loan shall be repaid by the Borrower in 16 equal quarterly installments commencing after a moratorium of one year from the date of disbursement or such other date as may be advised by Exim Bank at the time of first disbursement. Margin : 21% Extent and operation of the charge : The charge created in favour of Exim Bank shall rank as a first pari passu charge over the entire movable fixed assets of the Borrower.
Short particulars of the property or asset(s) charged (including complete address and location of the property)	Whole of Borrower's moveable fixed assets.

FIXED ASSETS

· Land

· Factory Building

· Office Premises

· Plant and Machinery

· Furniture and Fixtures

· Electrical Installation

· Computers

· Office Equipment

· Vehicles

WEB SITE DETAILS

PROFILE

They are a pharmaceutical company aligned across two business verticals viz. Products and Services. Their Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. They have evolved their business and have, over the years, extended from manufacturing APIs and Intermediates to add CRAMS to their offerings, which has significant potential for the growth of their business.

BOARD OF DIRECTORS

Ajit Kamath, aged 41 years, is the Executive Chairman and Managing Director of their Company and was first appointed as an Additional Director in their Company on January 1, 2001. He holds a Bachelors Degree in Commerce from the University of Mumbai and has more than 12 years of experience in the pharmaceutical industry. Prior to joining their Company he has worked with CEAT Financial Services Limited and was one of the promoters of Arch Commerz Private Limited, which reverse-merged into their Company pursuant to the Scheme of Rehabilitation. He has been instrumental in the acquisitions made by their Company since their acquisition of the Gurgaon Unit in December 2004. He has been involved and instrumental in planning and formulating the overall business strategy and developing business relations for their Company.

T Mallikarjuna Reddy, aged 50 years, is the Executive Vice-Chairman of their Company and was first appointed as an Additional Director in their Company on November 4, 1993. He holds a Masters Degree in Arts from the Andhra University. He has over 17 years experience in the pharmaceutical industry. He plays an active role in the operations of Company and reviews the functioning of their manufacturing facilities situated in Andhra Pradesh. He also assists in formulation of corporate policy and strategies for their Company. Prior to joining their Company he has worked with United India Insurance Company Limited.

Manoj Jain, aged 40 years, is the Deputy Managing Director and Chief Financial Officer of their Company and was first appointed as an Additional Director in their Company on January 1, 2001. He is a fellow member of the Institute of Chartered Accountants of India and also holds a Bachelors Degree in Commerce from the University of Mumbai. He was one of the promoters of Arch Commercial Private Limited, which reverse-merged into their Company pursuant to the Scheme of Rehabilitation and has more than 12 years of experience in the pharmaceutical industry. He has been instrumental in planning and formulating the overall business strategy of their Company. He is the Chief Financial Officer of their Company and is overall in-charge of the accounting and finance functions of their Company. He is also responsible for the statutory and secretarial affairs and the audit and taxation related activities of their Company. He is also instrumental in the formulation of corporate policy, strategic and perspective planning and external relations for their Company.

Rajendra Kaimal, aged 37 years, is the Executive Director of their Company and was first appointed as an Additional Director in their Company on November 1, 2003. He holds a Bachelors Degree in Commerce from the University of Mumbai. He has completed his Masters in Management Studies from Narsee Monjee Institute of Management Studies, Mumbai and is a Cost Accountant from the Institute of Cost and Works Accountants of India. He was one of the promoters of Arch Commerz Private Limited, which reverse-merged into their Company pursuant to the Scheme of Rehabilitation and has over 11 years of experience in the pharmaceutical industry. He is over-all in-charge of overseeing the commercial operations of their Company including purchase and export functions. He is also responsible for day-to-day co-ordination between all the manufacturing facilities of their Company.

Vandana Rajadhyaksha, aged 38 years, was appointed as a Nominee Director in their Company on behalf of ICICI Venture, acting as an investment manager to India Advantage Fund I, India Advantage Fund II, India Advantage Fund V and Rainbow Fund, pursuant to the terms of the Common Shareholders Agreement, with effect from July 19, 2007. She is a Metallurgical Engineer from Indian Institute of Technology, Mumbai and has also completed her Management Degree in Business Administration from the University of Pune. She has over 12 years of experience in the manufacturing, consulting and financial services sectors. She also has extensive experience in appraisal of projects in the e-business, retail, hospitality and financial services sectors and is a manager of their Company’s portfolio with ICICI Venture. Prior to joining ICICI Venture, she was associated with Tata Special Steels Limited for 3 years before spending a year with the consulting practice of KPMG.

Dr. Hira Sadhak, aged 60 years, is an Independent Director of their Company and was appointed as an Additional Director on December 9, 2010. He holds a Bachelor’s Degree in Economics from Calcutta University and a Master’s Degree in Economics from the University of Kalyani, West Bengal. He also holds a PhD in Industrial Finance from University of Pune. He has more than 30 years of experience in the financial services industry, financial sector research and management experiences in pension fund, mutual fund, life insurance and banking companies. He has in his career held various prestigious positions in the pension fund, mutual fund, life insurance and banking companies such as the managing director and chief executive officer of LIC Pension Fund Limited, joint general manager of LIC Mutual Fund and executive director with Life Insurance Corporation of India. He has been instrumental in drafting of key policies in his position as a member of Technical Committee on Accounting Policy for National Pension Scheme, Pension Fund Regulatory and Development Authority, Technical Advisory Group on Real Estate Price Index for India, Working Group on Household Savings, 10th and 11th Planning Commission and Working Group Fifth Economic Census, India.

Dr. Shailesh Mehta, aged 61 years, is an Independent Director on the Board of their Company and was appointed as an Additional Director in their Company on December 9, 2010. He holds a Degree in B.Tech. in mechanical engineering from Indian Institute of Technology, Mumbai and M.S. in Operations Research from Case Western Reserve University, USA. He also holds a PhD in Operation Research and Computer Science from Case Western Reserve University. He is the managing general partner of Granite Hill Capital Partners and is the president of Granite Hill Capital Ventures, a family asset management and advisory firm. He has served as the Chairman of the Board and CEO of Providian Financial Corporation (1986-2001) a Fortune 500 company, (currently part of JP Morgan-Chase). He has also served as operating general partner of West Bridge Capital (2001-2004) (now Sequoia India). He has also served as president and COO of Capital Holding.

Dr. Shantilal Jain, aged 48 years, is an Independent Director on the Board of their Company and was appointed as an Additional Director in their Company on January 24, 2011. He is a practicing physician and has completed his MBBS from Grant Medical College, Mumbai. He also holds a MD in General Medicine form Grant Medical College, Mumbai. He has more than 20 years of experience in the field of medicine. He has in his career authored various books and research papers and has been a faculty member at the YMT Medical College, Mumbai.

Puthenveetil J. Vincent, aged 66 years, is an Independent Director on the Board of their Company and was appointed as an Additional Director in their Company on December 9, 2010. He holds a Bachelor’s degree in Commerce from University of Calcutta. He has also completed a Management Development Programme from Indian Institute of Public Administration, New Delhi. He has more than three decades of experience in the field of higher financial management with the Government of India. He was a member of the Indian Civil Account Services (ICAS) and was responsible for expenditure control, internal audit of government departments, banks and financial institutions. In his career as an ICAS he has acted as a financial adviser to the Union Ministry of Finance and the Union Ministry of Home Affairs. He has also acted as the Chief Controller of Accounts, Union Ministry of Finance and as Controller of Aid Accounts and Audit (CAA and A), responsible for audit of external aid and monitoring, disbursement and accountant of foreign aid. He has also held senior positions as Financial Controller, Union Ministry of Civil Aviation and Tourism and Director (Finance) of Ministry of Surface Transport.

Ramakant Nayak, aged 65 years, is an Independent Director on the Board of their Company and was appointed as an Additional Director in their Company on January 24, 2011. He holds a Bachelor’s degree in Science from Karnataka University and Bachelor’s Degree in Law from University of Mumbai. He is also a member of Indian Banks Association Standing Committee of Private Sector Banks. He has, in his more than 40 years of experience in the commercial banking sector, held various prestigious positions in the banking industry such as the chairman and chief executive officer of the Lakshmi Vilas Bank Limited and managing director and chief executive officer of the Lord Krishna Bank Limited.

CMT REPORT (Corruption, Money Laundering & Terrorism]

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

1] INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

2] Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

3] Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

4] Record on Financial Crime :

Charges or conviction registered against subject: None

5] Records on Violation of Anti-Corruption Laws :

Charges or investigation registered against subject: None

6] Records on Int’l Anti-Money Laundering Laws/Standards :

Charges or investigation registered against subject: None

7] Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

8] Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

9] Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

10] Press Report :

No press reports / filings exists on the subject.

CORPORATE GOVERNANCE

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

CONTRAVENTION

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs. 53.26
UK Pound	1	Rs. 82.09
Euro	1	Rs. 68.90

SCORE & RATING EXPLANATIONS

SCORE FACTORS	RANGE	POINTS
HISTORY	1~10	7
PAID-UP CAPITAL	1~10	6
OPERATING SCALE	1~10	7
FINANCIAL CONDITION
--BUSINESS SCALE	1~10	6
--PROFITABILIRY	1~10	6
--LIQUIDITY	1~10	7
--LEVERAGE	1~10	6
--RESERVES	1~10	7
--CREDIT LINES	1~10	7
--MARGINS	-5~5	--
DEMERIT POINTS
--BANK CHARGES	YES/NO	YES
--LITIGATION	YES/NO	NO
--OTHER ADVERSE INFORMATION	YES/NO	NO
MERIT POINTS
--SOLE DISTRIBUTORSHIP	YES/NO	NO
--EXPORT ACTIVITIES	YES/NO	YES
--AFFILIATION	YES/NO	YES
--LISTED	YES/NO	NO
--OTHER MERIT FACTORS	YES/NO	YES
TOTAL		59

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
-	NB	New Business	-

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.